首页 | 本学科首页   官方微博 | 高级检索  
     


Use of cytarabine and idarubicin in a newly diagnosed AML patient with a severe wound
Authors:Humeyra Bozoglan  Ulku Ergene  Levent Yoleri
Affiliation:aCelal Bayar University Medical Faculty, Internal Medicine, Manisa, Turkey;bCelal Bayar University Medical Faculty, Division of Hematology, Manisa, Turkey;cCelal Bayar University Medical Faculty, Plastic and Reconstructive Surgery, Manisa, Turkey
Abstract:Acute myeloid leukemia (AML) is malignant tumor of haemopoietic precursor cells of non-lymphoid lineage. AML can atypically present with non-spesific cutaneous lesions or wounds. There are rare acute leukemia cases which present with genital ulcerations or pyoderma gangrenosum in the literature. The effect of acute leukemia on wound healing is not known, but it is thought that cytopenias and chemotherapy can impair wound healing in patients with leukemia. The effects of chemotherapeutic agents on wound healing are arguable. Here we present wound care strategies and simultaneously applied chemotherapy in an AML patient.
Keywords:Acute myeloid leukemia   Wound healing   Chemotherapy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号